Search - tctmd.com

Displaying 621 - 640 of 725

Sort: Relevancy | Date

News Industry News

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

September 15, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Todd Neale

September 13, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Daily News

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

September 02, 2014

News Industry News

Sorin Group Announces CE Mark Approval for CROWN PRT(TM) Heart Valve

July 24, 2014

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

News Industry News

Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion

July 17, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

July 02, 2014

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

News Industry News

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

May 07, 2014

News Daily News

Oral Anticoagulation Underused in Japanese A-fib Patients Undergoing PCI

Caitlin E. Cox

April 30, 2014

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Daily News

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

Yael L. Maxwell

April 17, 2014

News Industry News

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

March 24, 2014

News Daily News

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Yael L. Maxwell

January 01, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Rivaroxaban Antidote Appears Safe, Effective in Early Study

December 30, 2013

Advertisement

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

Sorin Group Announces CE Mark Approval for CROWN PRT(TM) Heart Valve

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

Benefit of LAA Closure Becomes Most Evident After 1 Year

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

Oral Anticoagulation Underused in Japanese A-fib Patients Undergoing PCI

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Rivaroxaban Antidote Appears Safe, Effective in Early Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content